Health
Mouse-adapted SARS-CoV-2 model helps advance the development of COVID-19 vaccines – News-Medical.Net
A new COVID-19 mouse model developed at the University of North Carolina at Chapel Hill captures many of the features of human disease and has helped advance a COVID-19 vaccine candidate to clinical trial.
Reviewed by Emily Henderson, B.Sc.Aug 27 2020
A new COVID-19 mouse model developed at the University of North Carolina at Chapel Hill captures many of the features of human disease and has helped advance a COVID-19 vaccine candidate to clinical trial.
Researchers, among them virologists and microbiologists at UNC-Chapel Hill’s Gillings School of Global Public Health, describe the mouse-adapted SARS-CoV-2 model in a paper fast-tracked and published Aug. 27 in Nature.
Small animal models that r…
-
Noosa News23 hours agoThis 42-Kilometre Walking Trail on the NSW North Coast Weaves Through Ancient Rainforest, Volcanic Mountains and Spectacular Waterfalls
-
Noosa News21 hours agoEaster weather forecast: What to expect in Sydney, Perth, Melbourne, Brisbane, Adelaide and Canberra
-
Noosa News21 hours agoQueensland cop cleared by court of stealing watches during anti-gang raid
-
Noosa News22 hours agoAnother power station confirmed offline as political fallout continues amid cultural issues